Liquid biopsy enables genomic profiling in prostate cancer with high success rates. Learn more about its potential as a ...

Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.

Modern technology could help lower barriers to developing therapies for rare diseases, writes Dr. Rowland Illing, chief ...

A team at Rice University has built a lab platform that can map the activity of more than 10 million protein variants in a ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

A federally funded study is coming to Minnesota to determine if whole genome sequencing at birth can reduce childhood diseases and deaths while satisfying growing concerns over genetic privacy and ...

New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...

(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...

New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have used a genetic sequencing technique called whole exome sequencing to discover a new ...